Vakiener Victoria — SEC Form 4 filings
SEC reporting owner CIK 1826263. 8 Form 4 filings on record with FilingPulse; latest filed 2025-12-23.
Transaction summary — filings shown
Covers all 8 filings on record, filed 2024-01-16 to 2025-12-23. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 7 legs across 4 filings — 25,553 shares, $1,098,298 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 8.
- Largest priced transaction: sale of 5,281 shares @ $67.97 ($358,950) in ARROWHEAD PHARMACEUTICALS, INC., filed 2025-12-23.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | Director | 6 | — | 7 legs · 25,553 sh · $1,098,298 | 2 |
| CHIMERIX INC (CMRX) | Director | 2 | — | — | 6 |
Form 4 filings — Vakiener Victoria
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2025-12-23 | 4 | ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | Sale (S): 2,799 @ $66.63 · Sale (S): 5,281 @ $67.97 · Sale (S): 1,960 @ $68.39 | EDGAR |
| 2025-12-18 | 4 | ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | Grant/award (A): 7,819 @ $0 | EDGAR |
| 2025-04-21 | 4 | CHIMERIX INC (CMRX) | Disposition to issuer (D): 60,000 (derivative) · Disposition to issuer (D): 35,000 (derivative) · Disposition to issuer (D): 50,000 (derivative) · Disposition to issuer (D): 60,000 (derivative) · Disposition to issuer (D): 60,000 (derivative) | EDGAR |
| 2024-12-20 | 4 | ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | Grant/award (A): 16,733 @ $22.99 | EDGAR |
| 2024-12-18 | 4 | ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | Sale (S): 8,994 @ $21.91 | EDGAR |
| 2024-06-21 | 4 | CHIMERIX INC (CMRX) | Grant/award (A): 60,000 (derivative) @ $0 | EDGAR |
| 2024-05-06 | 4 | ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | Sale (S): 1,799 @ $23.31 | EDGAR |
| 2024-01-16 | 4 | ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | Sale (S): 3,620 @ $37.87 · Sale (S): 1,100 @ $38.84 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1826263 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →